Industry letter of support for Every Prescription Conveyed Securely Act
We write to thank you for your leadership on the Every Prescription Conveyed Securely Act and urge your colleagues in Congress to support this vital legislation. The opioid crisis is devastating families and communities from coast to coast. In 2015, more than 33,000 Americans, according to the Centers for Disease Control, died as a result of the crisis, a number that is only growing.
Read the full letter
Surescripts Position on DEA Third Party Audit Requirements
Surescripts would like to take this opportunity to point out that neither the DEA's EPCS IFR, nor subsequent published guidance, requires end-user hospitals, physicians or pharmacies to have their security practices approved or participate in a security assessment.
Click here to read the full position statement from Surescripts
Surescripts EPCS Update to State Boards of Pharmacy
This is a memo sent to State Boards of Pharmacy, State Controlled Substance Agencies, and State and National Pharmacy Organizations as an update on industry progress in implementing electronic prescribing for controlled substances.
Click here to read the EPCS update letter.
Surescripts comments to the DEA Interim Final Rule on E-Prescribing for Controlled Substances
Surescripts applauds the publication of this groundbreaking Internal Final Rule (IFR), which we believe is a substantial step forward from the NPRM that the DEA published in the Federal Register in 2008.
Click here to read the entire letter.
A Primer on Controlled Substances
by Ken Whittemore
To set the stage, a passage from the DEA's web site:
"Many of the narcotics, depressants and stimulants manufactured for legitimate medical use are subject to abuse, and have therefore been brought under legal control. The goal of controls is to ensure that these "controlled substances" are readily available for medical use, while preventing their distribution for illicit sale and abuse."
Click here to read the entire primer.